Long-term Follow-up of Subjects With Transfusion-Dependent β-Thalassemia (TDT) Treated With Ex Vivo Gene Therapy
Clinical trial NCT02633943 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02633943
- Sponsor
- Genetix Biotherapeutics Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2014-01-01
- Primary completion
- 2035-11-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.